Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
432 | 3 | TRAIL//SURVIVIN//APOPTOSIS | 28744 |
2278 | 2 | NF KAPPA B//A20//I KAPPA B | 4873 |
32511 | 1 | DHMEQ//DEHYDROXYMETHYLEPOXYQUINOMICIN//MOL TARGET MED | 150 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | DHMEQ | authKW | 6112361 | 27% | 73% | 40 |
2 | DEHYDROXYMETHYLEPOXYQUINOMICIN | authKW | 1309161 | 6% | 69% | 9 |
3 | MOL TARGET MED | address | 1105366 | 7% | 48% | 11 |
4 | DEHYDROXYMETHYLEPOXYQUINOMICIN DHMEQ | authKW | 1080580 | 4% | 86% | 6 |
5 | MOL TARGET MED SCREENING | address | 1055935 | 9% | 36% | 14 |
6 | 9 METHYLSTREPTIMIDONE | authKW | 630340 | 2% | 100% | 3 |
7 | DTCM G | authKW | 420226 | 1% | 100% | 2 |
8 | EPOXYQUINOL DERIVATIVES | authKW | 420226 | 1% | 100% | 2 |
9 | LUMINACIN | authKW | 420226 | 1% | 100% | 2 |
10 | DTCM GLUTARIMIDE | authKW | 280150 | 1% | 67% | 2 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Oncology | 563 | 33% | 0% | 49 |
2 | Chemistry, Organic | 211 | 18% | 0% | 27 |
3 | Chemistry, Medicinal | 173 | 11% | 0% | 16 |
4 | Immunology | 128 | 15% | 0% | 23 |
5 | Pharmacology & Pharmacy | 103 | 17% | 0% | 26 |
6 | Transplantation | 46 | 4% | 0% | 6 |
7 | Medicine, Research & Experimental | 18 | 5% | 0% | 8 |
8 | Microbiology | 13 | 5% | 0% | 8 |
9 | Allergy | 9 | 1% | 0% | 2 |
10 | Biotechnology & Applied Microbiology | 8 | 5% | 0% | 7 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | MOL TARGET MED | 1105366 | 7% | 48% | 11 |
2 | MOL TARGET MED SCREENING | 1055935 | 9% | 36% | 14 |
3 | IST BIOMED MOL IMMUNOL ALBERTO MONROY | 210113 | 1% | 100% | 1 |
4 | LMFBI | 210113 | 1% | 100% | 1 |
5 | MOL MED INT HLTH RADIAT | 210113 | 1% | 100% | 1 |
6 | PATHOPHYSIOL ALLERGOL | 210113 | 1% | 100% | 1 |
7 | TUMOR CELL BIOL MINATO KU | 157580 | 2% | 25% | 3 |
8 | SAFETY BLOOD BIOL | 118184 | 2% | 19% | 3 |
9 | ANIM REOURCES DEV | 105056 | 1% | 50% | 1 |
10 | ANTI AGING ORTHOPED | 105056 | 1% | 50% | 1 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | ONCOLOGY RESEARCH | 7961 | 5% | 1% | 7 |
2 | JOURNAL OF ANTIBIOTICS | 1112 | 4% | 0% | 6 |
3 | BIOMEDICINE & PHARMACOTHERAPY | 659 | 3% | 0% | 4 |
4 | INTERNATIONAL JOURNAL OF ONCOLOGY | 531 | 3% | 0% | 5 |
5 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 511 | 5% | 0% | 8 |
6 | CANCER SCIENCE | 503 | 2% | 0% | 3 |
7 | DRUG RESISTANCE UPDATES | 427 | 1% | 0% | 1 |
8 | CANCER LETTERS | 417 | 3% | 0% | 5 |
9 | NEPHRON EXPERIMENTAL NEPHROLOGY | 417 | 1% | 0% | 1 |
10 | CANCER RESEARCH AND TREATMENT | 337 | 1% | 0% | 1 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |